Upstream Bio, Inc.

NASDAQ:UPB

Biotechnology

Healthcare
$2.00 +1.63%

+$0.10 today

Market cap
$109.62M
Beta
1.11
P/E (TTM)
-2.2
EPS (TTM)
-$2.89
52W Low $5.85High $33.68

Volume 0.86M

Average 0.66M

Balance Sheet

Inspect the capital base behind the business.

Assets

$353.77M

FY 2025 · Annual

-26.6% YoY

Liabilities

$14.00M

FY 2025 · Annual

+18.0% YoY

Equity

$339.77M

FY 2025 · Annual

-27.7% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents17.05M25.83M325.89M101.58M
Short-term Investments083.98M144.56M239.93M
Net Receivables412K236K1.18M668K
Inventory0000
Other Current Assets233K370K494K9.62M
Total Current Assets18.31M117M479.16M351.8M
Property, Plant & Equipment (Net)164K202K2.37M1.78M
Goodwill0000
Intangible Assets0000
Long-term Investments0000
Tax Assets0000
Other Non-current Assets7K(1)194K194K
Total Non-current Assets171K202K2.56M1.98M
Total Assets18.48M117.2M481.72M353.77M
Account Payables712K1.99M4.04M2.73M
Short-term Debt000720K
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities893K2.17M2.7M10.01M
Total Current Liabilities4.86M6.52M10.74M13.45M
Long-term Debt000549K
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities119.77M233.81M00
Total Non-current Liabilities119.78M233.81M1.13M549K
Total Liabilities124.63M240.32M11.87M14M
Common Stock3K3K53K54K
Retained Earnings(107.44M)(127.97M)(190.78M)(334.22M)
Accumulated OCI021K(25K)530K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(106.16M)(123.13M)469.85M339.77M
Total Debt94K45K1.83M1.27M
Net Debt(16.96M)(25.79M)(324.06M)(100.31M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$96.7M
Short-term Investments$197.9M
Receivables$1.0M
Other Current$20.7M
Total Current Assets$316.3M
PP&E (Net)$1.6M
Other Non-current$194.0K
Total Non-current Assets$1.8M
Total Assets$318.1M

Analysis

Selected assets total $318.1M for Latest. The largest visible component is Short-term Investments at $197.9M, about 62.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

How much cash does UPB have?

Upstream Bio, Inc. (UPB) reported $101.58M in cash and equivalents in fiscal 2025.

How much debt does UPB carry?

Upstream Bio, Inc. (UPB) reported $1.27M of total debt, with net debt of -$100.31M.